“Design and Rational of the OPTIMA Study: Retreatment or Step-Up Therapy With Omalizumab in Patients With Chronic Idiopathic Spontaneous Urticaria (CIU CSU)”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s125. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/184.